528MO Is re-introduction or continuation of PARP inhibitors after local therapy for oligo-metastatic progression in patients with relapsed ovarian cancer relevant?
Saved in:
| Title: | 528MO Is re-introduction or continuation of PARP inhibitors after local therapy for oligo-metastatic progression in patients with relapsed ovarian cancer relevant? |
|---|---|
| Authors: | Thibault, G.1 (AUTHOR), Kfoury, M.2 (AUTHOR), Lorusso, D.3 (AUTHOR), Floquet, A.4 (AUTHOR), Ventriglia, J.5 (AUTHOR), Salaun, H.6 (AUTHOR), Moubarak, M.7 (AUTHOR), Rivoirard, R.8 (AUTHOR), Polastro, L.9 (AUTHOR), Favier, L.10 (AUTHOR), You, B.11 (AUTHOR), Berton-Rigaud, D.12 (AUTHOR), De La Motte Rouge, T.13 (AUTHOR), Mansi, L.14 (AUTHOR), Abdeddaim, C.15 (AUTHOR), Prulhiere, K.16 (AUTHOR), Lancry Lecomte, L.17 (AUTHOR), Provansal Gross, M.18 (AUTHOR), Dalban, C.19 (AUTHOR), Ray-Coquard, I.L.20 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS787-S788. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 159077451 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 528MO Is re-introduction or continuation of PARP inhibitors after local therapy for oligo-metastatic progression in patients with relapsed ovarian cancer relevant? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Thibault%2C+G%2E%22">Thibault, G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kfoury%2C+M%2E%22">Kfoury, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Floquet%2C+A%2E%22">Floquet, A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ventriglia%2C+J%2E%22">Ventriglia, J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salaun%2C+H%2E%22">Salaun, H.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moubarak%2C+M%2E%22">Moubarak, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rivoirard%2C+R%2E%22">Rivoirard, R.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Polastro%2C+L%2E%22">Polastro, L.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Favier%2C+L%2E%22">Favier, L.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22You%2C+B%2E%22">You, B.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berton-Rigaud%2C+D%2E%22">Berton-Rigaud, D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+La+Motte+Rouge%2C+T%2E%22">De La Motte Rouge, T.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mansi%2C+L%2E%22">Mansi, L.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdeddaim%2C+C%2E%22">Abdeddaim, C.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prulhiere%2C+K%2E%22">Prulhiere, K.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lancry+Lecomte%2C+L%2E%22">Lancry Lecomte, L.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Provansal+Gross%2C+M%2E%22">Provansal Gross, M.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dalban%2C+C%2E%22">Dalban, C.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ray-Coquard%2C+I%2EL%2E%22">Ray-Coquard, I.L.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS787-S788. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159077451 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2022.07.656 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S787 Titles: – TitleFull: 528MO Is re-introduction or continuation of PARP inhibitors after local therapy for oligo-metastatic progression in patients with relapsed ovarian cancer relevant? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Thibault, G. – PersonEntity: Name: NameFull: Kfoury, M. – PersonEntity: Name: NameFull: Lorusso, D. – PersonEntity: Name: NameFull: Floquet, A. – PersonEntity: Name: NameFull: Ventriglia, J. – PersonEntity: Name: NameFull: Salaun, H. – PersonEntity: Name: NameFull: Moubarak, M. – PersonEntity: Name: NameFull: Rivoirard, R. – PersonEntity: Name: NameFull: Polastro, L. – PersonEntity: Name: NameFull: Favier, L. – PersonEntity: Name: NameFull: You, B. – PersonEntity: Name: NameFull: Berton-Rigaud, D. – PersonEntity: Name: NameFull: De La Motte Rouge, T. – PersonEntity: Name: NameFull: Mansi, L. – PersonEntity: Name: NameFull: Abdeddaim, C. – PersonEntity: Name: NameFull: Prulhiere, K. – PersonEntity: Name: NameFull: Lancry Lecomte, L. – PersonEntity: Name: NameFull: Provansal Gross, M. – PersonEntity: Name: NameFull: Dalban, C. – PersonEntity: Name: NameFull: Ray-Coquard, I.L. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2022 Supplement 7 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 33 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
